Login / Signup

A new negative allosteric modulator, AP14145, for the study of small conductance calcium-activated potassium (KCa 2) channels.

Rafel Simó-VicensJeppe E KirchhoffBernardo DolceLea AbildgaardTobias SpeerschneiderUlrik S SørensenMorten GrunnetJonas Goldin DinessBo Hjorth Bentzen
Published in: British journal of pharmacology (2017)
AP14145 is a negative allosteric modulator of KCa 2.2 and KCa 2.3 channels that shifted the calcium dependence of channel activation, an effect strongly dependent on two identified amino acids. AP14145 prolonged AERP in rats and did not trigger any acute CNS effects in mice. The understanding of how KCa 2 channels are inhibited, at the molecular level, will help further development of drugs targeting KCa 2 channels.
Keyphrases
  • transcription factor
  • small molecule
  • amino acid
  • liver failure
  • blood brain barrier
  • cancer therapy
  • metabolic syndrome
  • intensive care unit
  • drug delivery
  • single molecule
  • aortic dissection